HLS
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Healius Limited is an Australian pathology and diagnostic services provider. The company operates a network of collection centres and laboratories across Australia, offering specialty pathology, clinical trials, and genomics testing. Its services include blood testing, cardiovascular disease diagnostics, and pharmacogenomics (PGx) reports. Healius serves consumers and referring practitioners, utilizing AI-based tools to support healthcare access.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Health Care Equipment & Services Homepage healius.com.au
Sector Healthcare IR page —
Tags
pathology services, clinical trials, genomics testing, pharmacogenomics, blood testing, diagnostic centres, cardiovascular diagnostics, Western Diagnostic Pathology, WDP, PGx report
Press page —

Metrics

Valuation  
Market cap A$ 352.197M
Market cap (USD) $ 246.976M
P/E -0.96
PEG —
P/BV 0.01
P/S 0.26
P/OCF 1.67
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE -107.7%
ROI -151.0%
ROIC -151.0%
Profit margin -29.8%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock —
Diluting (TTM) No
Debt/Equity 57.9%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -20.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Revenue 1.373B 1.344B 1.746B 1.707B 2.336B 1.901B 1.585B 1.562B 1.705B
Net profit -408.9M -563M -636M -380M 294M 66.3M 72M 57.2M 4.1M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Share price 0.59 — — — — — — — —
P/OCF 0.01 — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Change in substantial holding Bull 0 Bear 0 Routine

Prompts

Healius Limited (ticker HLS), listed in Australia.

ETFs Holding Healius Limited

ETF Weight in ETF Shares Market value As of
AVDS 0.01% 48,385 $ 18.845K Nov 16, 2026
DISV 0.01% 1,082,611 $ 398.119K Nov 12, 2026
DFIS 0.01% 958,764 $ 352.576K Nov 12, 2026
DFIC 0.00% 632,241 $ 232.5K Nov 12, 2026
DFSI 0.00% 10,855 $ 3,991.81 Nov 12, 2026
AVDE 0.00% 287,293 $ 113.519K Nov 16, 2026
AVDV 0.00% 1,223,817 $ 476.66K Nov 16, 2026
AVSD 0.00% 46,624 $ 18.159K Nov 16, 2026